Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |